PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
All content for PeerVoice Digestive Diseases Video is the property of PeerVoice and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Marla C. Dubinsky, MD / David T. Rubin, MD - TNF Inhibitors in Inflammatory Bowel Disease: How Can We Realize Opportunities to Optimize Clinical and Patient Outcomes?
PeerVoice Digestive Diseases Video
57 minutes 1 second
5 months ago
Marla C. Dubinsky, MD / David T. Rubin, MD - TNF Inhibitors in Inflammatory Bowel Disease: How Can We Realize Opportunities to Optimize Clinical and Patient Outcomes?
Visit https://www.peervoice.com/XAD860 to view the entire programme with slides. After completing “Marla C. Dubinsky, MD / David T. Rubin, MD - TNF Inhibitors in Inflammatory Bowel Disease: How Can We Realize Opportunities to Optimize Clinical and Patient Outcomes?”, participants will be able to: Recall the evidence of the impact of tumor necrosis factor (TNF) inhibitors on endoscopic outcomes in patients with inflammatory bowel disease (IBD); Use clinical data to illustrate the potential benefits of early intervention with; TNF inhibitors in patients with IBD; Explain the importance of maintaining a steady, stable serum drug level during maintenance treatment of IBD with a TNF inhibitor; and Apply recommended approaches for effective and safe management of patients receiving TNF inhibitor-based maintenance therapy that optimizes both clinical and patient outcomes.
PeerVoice Digestive Diseases Video
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
